Back
Kymera Therapeutics Stock Price Chart
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.
Buy
71
KYMR
Kymera Therapeutics
Last Price:
46.27
Seasonality Move:
65.72%
7 Day Trial
ALL ACCESS PASS
$
7
The truth about AI stocks (must see)
Learn the names of all 10 stocks here. FREE.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Kymera Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.58 | Buy |
| 20-day SMA: | 46.67 | Buy |
| 50-day SMA: | 46.11 | Buy |
| 200-day SMA: | 38.62 | Buy |
| 8-day EMA: | 45.67 | Buy |
| 20-day EMA: | 45.85 | Buy |
| 50-day EMA: | 45.2 | Buy |
| 200-day EMA: | 38.5 | Buy |
Kymera Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 59.12 | Buy |
| Chaikin Money Flow: | 317205 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.81 - 49.49) | Buy |
| Bollinger Bands (100): | (34.86 - 47.92) | Buy |
Kymera Therapeutics Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics Stock
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 49.02 while KYMR 8-day simple moving average is 44.58, which is a Buy signal.
- The stock price of KYMR is 49.02 while Kymera Therapeutics 20-day SMA is 46.67, which makes it a Buy.
- Kymera Therapeutics 50-day simple moving average is 46.11 while KYMR share price is 49.02, making it a Buy technically.
- KYMR stock price is 49.02 and Kymera Therapeutics 200-day simple moving average is 38.62, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
71
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy or a Sell?
-
Kymera Therapeutics stock is rated a Buy
The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics Stock Info
Market Cap:
3.03B
Price in USD:
49.02
Share Volume:
339.81K
Kymera Therapeutics 52-Week Range
52-Week High:
53.27
52-Week Low:
9.60
Buy
71
Kymera Therapeutics (KYMR)
is a Buy
Kymera Therapeutics Share Price Forecast
-
What is the Kymera Therapeutics stock price today?
The Kymera Therapeutics stock price is 49.02 USD today. -
Will KYMR stock go up or go down?
Kymera Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Kymera Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics is not overvalued.
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 49.02 while KYMR 8-day exponential moving average is 45.67, which is a Buy signal.
- The stock price of KYMR is 49.02 while Kymera Therapeutics 20-day EMA is 45.85, which makes it a Buy.
- Kymera Therapeutics 50-day exponential moving average is 45.20 while KYMR share price is 49.02, making it a Buy technically.
- KYMR stock price is 49.02 and Kymera Therapeutics 200-day simple moving average is 38.50, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics
Is Kymera Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
Technical Analysis of Kymera Therapeutics
Should I short Kymera Therapeutics stock?
- KYMR Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting Kymera Therapeutics is a Sell
- Kymera Therapeutics Relative Strength Index (RSI) is 59.12, which suggest Kymera Therapeutics is overbought
- The Bollinger Bands (25) for Kymera Therapeutics is (43.81 - 49.49), which suggest Kymera Therapeutics is a Buy
- The Bollinger Bands (100) for Kymera Therapeutics is (34.86 - 47.92), which suggest Kymera Therapeutics is a Buy
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.